The Patent Finder
US

Aminoadamantane Derivatives as Therapeutic Agents

US 7,326,730 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Feb 22, 2020 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Nov 17, 2005 as application 11/283,241 · Granted Feb 5, 2008
Base term, 20 years from filing
Today
20 years from filing
Term ended Feb 22, 2020
2000 2026
Clock starts
Feb 22, 2000
Term ended
Feb 22, 2020
Granted
Feb 5, 2008
base term after the term ends fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
43
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 22, 2000, when application 09/510,099, the earliest non-provisional in its chain, was filed (this one was filed Nov 17, 2005); a parent in its chain could not be resolved (the next row)Feb 22, 2020High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderFeb 22, 2020Medium confidence

This family

US 6,620,845Lapsed on the fee record
Sep 2015
Sep 2015
Application 60/630,885Provisional application
no patent term
no patent term
US 7,326,730this patent
Feb 2020
Feb 2020
US 7,619,007Term ended
no later than Nov 2025
no later than Nov 2025
US 8,058,291In force
Dec 2029
Dec 2029
Application PCT/US2006/013506PCT application
no patent term
no patent term
Application PCT/US2007/011887PCT application
no patent term
no patent term
US 8,168,209Term ended
Jul 2026
Jul 2026
8 of 43 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 14, 2007
Reel 19829, frame 122
Neuromolecular, Inc.Neuromolecular Pharmaceuticals, Inc.Change of Name
Sep 17, 2007
Reel 19831, frame 413
Neuromolecular Pharmaceuticals, Inc.Adamas Pharmaceuticals, Inc.Change of Name
Oct 1, 2013
Reel 31322, frame 613
Adamas Pharmaceuticals, Inc.Panorama Research, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited